Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,320.00    0.00 (0.00%)
Bid:
2,315.00
Ask:
2,320.00
Spread: 5.00 (0.216%)
Market Cap: £3.15b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

16 Sep 2024 07:00

RNS Number : 2184E
RIT Capital Partners PLC
16 September 2024
 

RIT Capital Partners plc (LEI: P31Q1NLTW35JJGHA4667)

 

16 September 2024

 

31 August 2024 Net Asset Value

 

RIT Capital Partners plc ("RIT") announces that its unaudited diluted net asset value ("NAV") as at 31 August 2024 (with debt at fair value) was 2,580p per £1 ordinary share (31 July 2024: 2,560p).

 

August 2024 Commentary and Highlights

 

RIT's NAV per share total return for August 2024 was +0.8%. The increase in the value of our portfolio was driven by positive performance across each of our three strategic investment pillars including Quoted Equities, Private Investments and Uncorrelated Strategies. Our meaningful US dollar position detracted from returns as sterling strengthened by 2.1%. Year to date, RIT's NAV per share total return was +7.2%.

 

RIT's positive performance for August was delivered against a volatile backdrop for global equities in the period. Global equity markets saw a meaningful correction at the start of the month as US unemployment numbers rose, while the Yen strengthened as the Bank of Japan prepared the market for further interest rate hikes. However, calm returned to the markets later in August as the US reported better employment figures and better than expected retail sales. European equities were choppy throughout the month but ended in positive territory, while Chinese domestic equities continued to lag the wider market.

 

Specific highlights for August include:

 

·

An increase in the value of our Quoted Equities book was driven by a range of contributing factors across both direct and underlying managers. This included gains from companies in our Quality theme, as well as ongoing upside from our exposure to specialist managers in Japan which continued to contribute positively to our performance despite the volatility seen in the TOPIX during August. Our portfolio hedges were also additive in the month despite the overall market finishing in the positive.

 

·

Private Investments were a solid contributor during the month, driven by gains from our private funds which saw an increase in Q2 valuations. As of 31 August, 97% of our private funds were held at 30 June reported valuations.

 

·

Investments in Uncorrelated Strategies also contributed positively to our total return for August, driven largely by holdings in credit managers and equity market neutral managers.

 

·

The Board of RIT continued its active buyback programme, generating a further accretive impact on the NAV per share and taking the volume of shares repurchased on behalf of shareholders to approximately 2.2 million for the year to 31 August 2024. Since the start of 2023, the Board has bought back nearly 7% of RIT's issued share capital, representing one of the largest share buybacks in the industry.

 

 

 

 

 

 

 

For more information:

J. Rothschild Capital Management Limited (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.ukinvestorrelations@ritcap.co.uk

 

Numis Securities Limited (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVDXLFFZKLLBBD
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20242:27 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20245:22 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSNet Asset Value(s)
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:56 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSFinal Results
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:32 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20245:13 pmRNSDirectorate Change
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSCompany Announcement
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSNet Asset Value(s)
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSNet Asset Value(s)
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20241:49 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.